neomycin

IPOL

IPV

IPOL is used for primary and booster vaccination of infants, children and adults to protect against infection with Type 1, Type 2 and Type 3 polioviruses causing poliomyelitis.

M-M-R® II

MMR

M-M-R® II is used for primary vaccination and revaccination of children and adults to protect against measles, mumps and rubella.

Influenza vaccine (brand names may vary year to year)

Influenza types in the vaccine usually change season to season

The influenza vaccine is given to protect against influenza in children older than six months of age and adults. The World Health Organization monitors influenza illness throughout the year and make recommendations on which three influenza types are likely to cause the most illness in the northern and in the southern hemisphere during their respective influenza seasons. Vaccine ingredients are specific to the brand of influenza vaccine they are associated with and may vary to year. Specific information on ingredients in the vaccines use each season can be found on the individual vaccine datasheets.

Infanrix®-IPV

DTaP-IPV

Infanrix®-IPV is used for primary and booster vaccination of infants and children up to their 7th birthday to protect against diphtheria, tetanus, pertussis and poliomyelitis.

Infanrix®-hexa

DTaP-IPV-HepB/Hib

Infanrix®-hexa is used for primary and booster vaccination of infants and children up to their 5th birthday to protect against diphtheria, tetanus, pertussis, hepatitis B, poliomyelitis and disease caused by Haemophilus influenzae type b.

 

Varivax®

Varicella

Varivax® is used for primary vaccination of children from 12 months of age and adults to protect against varicella-zoster infection (chickenpox). The vaccine may prevent or reduce the severity of chickenpox disease if it is given within 3-5 days of exposure to someone with the disease.

Varilrix®

Varicella

Varilrix® is used for primary vaccination of infants from nine months of age, children and adults to protect against varicella-zoster infection (chickenpox). The vaccine may prevent or reduce the severity of chickenpox disease if it is given within 3-5 days of exposure to someone with the disease.

Varilrix® is back in stock and available to order from 3 March 2014.

Subscribe to RSS - neomycin